SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Gmac Llc 7.375% Notes Due 8/8/2032 (GOM) trades at a trailing P/E of 5.9. Trailing earnings yield is 17.09%. PEG 0.12 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (5.9); PEG ≤ 1.0 — Peter Lynch undervalued (0.12); earnings yield beats bond yields (17.09%).
- PEG Ratio 0.12 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 17.09% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 73/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — GOM
Valuation Multiples
P/E (TTM)5.9
Forward P/EN/A
PEG Ratio0.12
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.57
EV/EBITDA0.0
Per Share Data
EPS (TTM)$4.34
Book Value / Share$0.00
Revenue / Share$16.17
FCF / Share$0.00
Yields & Fair Value
Earnings Yield17.09%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2010 |
$807.68 |
$11.45B |
$1.08B |
9.4% |
| 2011 |
$-117.96 |
$6.07B |
$-157M |
-2.6% |
| 2012 |
$898.59 |
$4.9B |
$1.2B |
24.4% |
| 2013 |
$266.35 |
$4.26B |
$361M |
8.5% |
| 2014 |
$2.39 |
$4.65B |
$1.15B |
24.7% |
| 2015 |
$2.67 |
$4.86B |
$1.29B |
26.5% |
| 2016 |
$2.21 |
$5.44B |
$1.07B |
19.6% |
| 2017 |
$2.04 |
$5.77B |
$929M |
16.1% |
| 2018 |
$2.95 |
$5.8B |
$1.26B |
21.8% |
| 2019 |
$4.34 |
$6.39B |
$1.72B |
26.8% |
